Skip to main content

Table 1 Clinical characteristics of individuals among the three groups

From: Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes

 

NW

OB

 

(mean ± SD)

(mean ± SD)

 

NC (n = 21)

MHO (n = 20)

MUO (n = 36)

P

Sex (Male : Female)

10:11

12:8

13:23

0.221

Age (y)

25.62 ± 3.78

26.05 ± 8.81

31.03 ± 8.52b

0.0072

BMI (kg/m2)

20.75 ± 1.43

36.66 ± 5.27a

37.34 ± 6.79a

<0.0012

SBP (mmHg)

115 ± 7

130 ± 11a

144 ± 19a

<0.0012

DBP (mmHg)

68 ± 7

83 ± 9a

91 ± 13a

<0.0012

WC (cm)

73.78 ± 7.72

110.90 ± 13.84a

109.58 ± 11.86a

<0.0013

ALT (U/L)

18.26 ± 15.43

67.72 ± 55.94a

70.02 ± 46.34a

<0.0012

AST (U/L)

21.94 ± 9.76

45.69 ± 32.18a

45.55 ± 29.43a

0.0012

TG (mg/dL)

68.05 ± 22.69

88.16 ± 28.11

202.72 ± 110.35ab

<0.0012

TC (mg/dL)

157.14 ± 23.60

183.89 ± 37.11a

200.23 ± 38.47a

<0.0013

LDL-c (mg/dL)

87.39 ± 20.40

116.73 ± 32.37a

133.13 ± 29.75a

<0.0013

HDL-c (mg/dL)

57.73 ± 12.54

46.72 ± 8.29a

40.82 ± 6.84a

<0.0012

Lp(a) (mg/L)

186.90 ± 189.80

201.35 ± 185.31

147.68 ± 170.52

0.5132

GIR30

10.92 ± 1.84

4.95 ± 1.54a

4.10 ± 1.46a

<0.0013

FPG (mg/dL)

89.13 ± 9.21

86.81 ± 11.41

115.46 ± 32.17ab

<0.0012

SCr (µmol/L)

69.03 ± 16.56

65.49 ± 12.12

63.89 ± 13.24

0.413

BUN(mmol/L)

4.79 ± 1.28

4.46 ± 0.91

4.70 ± 1.15

0.6263

UA (µmol/L)

348.99 ± 78.48

428.50 ± 119.09a

410.93 ± 89.65

0.0193

  1. Abbreviations: NW: normal weight; OB: obesity; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; WC: waist circumference; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TG: triglyceride; TC: total cholesterol; LDL-c: low-Density Lipoprotein cholesterol; HDL-c: high-Density Lipoprotein cholesterol; Lp(a): lipoprotein(a); FPG: fasting plasma glucose; SCr: serum creatinine; BUN: blood urea nitrogen; UA: uric acid
  2. 1 The categorical variables among three groups were compared via the chi-square test; 2The continuous variables among three groups that were not normally distributed or normally distributed variables with heterogeneity of variance were compared via nonparametric tests and with post hoc tests of Kruskal‒Wallis tests. 3 The continuous variables among the three groups that were normally distributed were compared via one-way ANOVA with Bonferroni correction
  3. a Significant differences (P < 0.05) were shown with the NC group through post hoc tests. b Significant differences (P < 0.05) were shown with MHO through post hoc tests